Two Phase 3 Trials of dupilumab versus placebo in atopic dermatitis

E.L. Simpson, T. Bieber, E. Guttman-Yassky, L.A. Beck, A. Blauvelt, M.J. Cork, J.I. Silverberg, M. Deleuran, Y. Kataoka, J.-P. Lacour, K. Kingo, M. Worm, Y. Poulin, A. Wollenberg, Y. Soo, N.M.H. Graham, G. Pirozzi, B. Akinlade, H. Staudinger, V. MasteyL. Eckert, A. Gadkari, N. Stahl, G.D. Yancopoulos, M. Ardeleanu, Biagio Didona

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2335-2348
Number of pages14
JournalNew England Journal of Medicine
Volume375
Issue number24
DOIs
Publication statusPublished - Dec 15 2016

Cite this

Simpson, E. L., Bieber, T., Guttman-Yassky, E., Beck, L. A., Blauvelt, A., Cork, M. J., ... Didona, B. (2016). Two Phase 3 Trials of dupilumab versus placebo in atopic dermatitis. New England Journal of Medicine, 375(24), 2335-2348. https://doi.org/10.1056/NEJMoa1610020